Clinical Research Directory
Browse clinical research sites, groups, and studies.
Intracoronary Bolus Only Compared With Intravenous Bolus and 12-hours Infusion of Abciximab in Non-ST Elevation Myocardial Infarction.
Sponsor: Seoul National University Hospital
Summary
Intracoronary bolus Abciximab single is non-inferior to intravenous and continuous 12- hours infusion in the size reduction of infarction on cardiac magnetic resonance in Non-ST elevation Myocardial infarction.
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
150
Start Date
2009-08
Completion Date
2012-12
Last Updated
2026-04-27
Healthy Volunteers
No
Conditions
Interventions
glycoprotein IIb/IIIa inhibitor (abciximab)
patients intracoronary bolus only group and intravenous bolus and 12-hours continuous infusion group bolus:0.25mg/kg body weight,continus 12hrs-0.125ug/kg per minute(maximum: 10ug/min)
Locations (1)
Department of Internal Medicine, Cardiovascular Center, Seoul National University Hospital
Seoul, South Korea